Aldosterone Reduction Rate After Saline Infusion Test May Be a Novel Prediction in Patients With Primary Aldosteronism
Authors:
- 1 October 2019
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (3) , e319-e327
Abstract
Objective: Accurate assessment and localization of aldosterone-producing adenomas (APAs) are essential for the treatment of primary aldosteronism (PA). Although adrenal venous sampling (AVS) is the standard method of reference for subtype diagnosis in PA, controversy exists concerning the criteria for its interpretation. This study aims to determine better indicators that can reliably predict subtypes of PA. Method: Retrospective, single-cohort analysis including 209 patients with PA who were subjected to AVS. Eighty-two patients whose plasma aldosterone concentrations (PAC) were normalized after surgery were histopathologically or genetically diagnosed with APA. The accuracy of image findings was compared to AVS results. Receiver operating characteristic (ROC) curve analysis between the operated and the no-apparent laterality groups was performed using AVS parameters and loading test for diagnosis of PA. Result: Agreement between image findings and AVS results was 56.3%. ROC curve analysis revealed that the lateralization index (LI) after adrenocorticotropin stimulation cutoff was 2.40, with 98.8% sensitivity and 97.1% specificity. The contralateral suppression index (CSI) cutoff value was 1.19, with 98.0% sensitivity and 93.9% specificity. All patients over the LI and CSI cutoff values exhibited unilateral subtypes. Among the loading test, the best classification accuracy was achieved using the PAC reduction rate after a saline infusion test (SIT) >33.8%, which yielded 87.2% sensitivity or a PAC after a SIT <87.9 pg/mL with 86.2% specificity for predicting bilateral PA. Conclusion: The combined criteria of the PAC reduction rate and PAC after the SIT can determine which subset of patients with APA who should be performed AVS for validation.Keywords
Funding Information
- Scientific Research (# 19H03708, # 18K08464, # 19K08972, # 18K08465, # 17K09875, # 19K17999)
- Naito Foundation, the Takeda Science Foundation, GSK Japan Research
- Hamaguchi Biochemistry Foundation
- Yamaguchi Endocrine Foundation
- Donated Fund of Next Generation Hormone Academy for Human Health & Longevity
This publication has 27 references indexed in Scilit:
- Adrenal vein sampling: Substantial need for technical improvement at regional referral centresClinical Biochemistry, 2013
- Detection of adrenal veins on selective retrograde CT adrenal venography in comparison with digital subtraction angiography in subjects with established diagnosis of one-sided adrenal aldosterone-producing tumor confirmed by adrenal vein sampling, histopathology and clinical courseInternational Journal of Cardiology, 2013
- Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary AldosteronismHypertension, 2012
- Consequences of Adrenal Venous Sampling in Primary Hyperaldosteronism and Predictors of Unilateral Adrenal DiseaseJournal of the American College of Surgeons, 2010
- Roles of Clinical Criteria, Computed Tomography Scan, and Adrenal Vein Sampling in Differential Diagnosis of Primary Aldosteronism SubtypesThe Journal of Clinical Endocrinology & Metabolism, 2008
- Is Primary Aldosteronism Rare or Common among Hypertensive Patients?Hypertension Research, 2007
- Localization of Aldosterone-Producing Adrenocortical Adenomas: Significance of Adrenal Venous SamplingHypertension Research, 2007
- A Prospective Study of the Prevalence of Primary Aldosteronism in 1,125 Hypertensive PatientsJACC, 2006
- Clinical Characteristics of Aldosterone-Producing Microadenoma, Macroadenoma, and Idiopathic Hyperaldosteronism in 93 Patients with Primary AldosteronismHypertension Research, 2006
- Role for adrenal venous sampling in primary aldosteronismSurgery, 2004